Literature DB >> 20708864

Clinical features of epilepsy with pervasive developmental disorder.

Toru Kurokawa1, Yuko Yokomizo, Sooyoug Lee, Tsuyoshi Kusuda.   

Abstract

PURPOSE: To clarify the clinical features of patients with epilepsy and pervasive developmental disorder (PDD).
METHODS: We examined 12 outpatients with epilepsy as well as PDD at Seiai Rehabilitation Hospital.
RESULTS: The patients comprised 7 males and 5 females. The initial neurological symptoms appeared between 5 months and 4 years of age. The interval between the initial neurological symptoms/developmental delay and seizure onset ranged from several months to twenty years. The seizures started at 10-19 years of age in 8 out of the 12 cases. The types of seizures were astatic-drop in 2 cases, tonic-to-astatic in one, atypical absence (decreased consciousness) and generalized tonic clonic seizures (GTCS) in 3 cases, GTCS in 4 cases, or myoclonic and psychomotor in 2 cases. The mental development distributed from normal to extremely severe retardation. Paroxysmal abnormalities on eegs were focal at the frontal area in 7 cases (58%) and other findings in 5 cases. Presumptive risk factors were prenatal in 6 cases (family history for PDD in 1 case, for epilepsy in 1, twin pregnancy in 2 cases, and other in 2 cases), perinatal in 2 patients, postnatal in 1, and unknown in 3 cases.
CONCLUSIONS: The seizures occurred most frequently after the onset of neurological symptoms or developmental delay. The frontal lobe dysfunction was associated with seizure onset in 58% of the cases based on the EEG findings. The risk factors were prenatal in 50% of the cases.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20708864     DOI: 10.1016/j.braindev.2010.05.008

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  1 in total

1.  Few individuals with Lennox-Gastaut syndrome have autism spectrum disorder: a comparison with Dravet syndrome.

Authors:  Na He; Bing-Mei Li; Zhao-Xia Li; Jie Wang; Xiao-Rong Liu; Heng Meng; Bin Tang; Wen-Jun Bian; Yi-Wu Shi; Wei-Ping Liao
Journal:  J Neurodev Disord       Date:  2018-03-20       Impact factor: 4.025

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.